Open-Source Initiative Circumvents Biotech Patents

Though agricultural biotechnology has the potential to transform small-scale farming in developing countries, such transformation faces a major bottleneck: the intellectual property landscape.

Written byAileen Constans
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Courtesy of Brian Weir, CAMBIA

This tobacco seedling, tranformed with Sinorhizobium meliloti, an alternative to Agrobacterium, is stained for β-glucuronidase (GUS) expression.

Though agricultural biotechnology has the potential to transform small-scale farming in developing countries, such transformation faces a major bottleneck: the intellectual property landscape. Case in point: Golden Rice, engineered to produce beta-carotene (a source of vitamin A), is subject to approximately 40 patents that initially hampered its dissemination to developing countries.

Further, if a scientist in the public sector, small biotech company, or developing country wishes to make improvements to a proprietary crop technology, the same patent jungle can make it difficult to transfer these improvements to farmers. "When you start having tens or hundreds of patents necessary to reduce to practice one idea, then it becomes untenable. And basically innovation grinds to a halt," especially for technologies that are not obviously profitable, says Richard Jefferson, CEO and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery